These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6274563)

  • 21. The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy: results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA).
    Liljedahl S; Kahan T; Lind L; Arnlöv J
    Echocardiography; 2009 Aug; 26(7):753-8. PubMed ID: 19486119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
    Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol.
    White WB; Schulman P; Karimeddini MK; Smith VE
    Am Heart J; 1989 Jan; 117(1):145-50. PubMed ID: 2521417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased cardiac performance in mild essential hypertension. Left ventricular mechanics.
    Lutas EM; Devereux RB; Reis G; Alderman MH; Pickering TG; Borer JS; Laragh JH
    Hypertension; 1985; 7(6 Pt 1):979-88. PubMed ID: 2934328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of left ventricular hypertrophy after one-year treatment with clonidine: relationship between echocardiographic findings, blood pressure, and urinary catecholamines.
    Timio M; Venanzi S; Gentili S; Ronconi M; Del Re G; Del Vita M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S142-6. PubMed ID: 2455168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral vs beta-blocker therapy in patients with primary hypertension: effects on blood pressure, left ventricular function and mass, and the pressor surge of social stress anger.
    Lee DD; DeQuattro V; Allen J; Kimura S; Aleman E; Konugres G; Davison G
    Am Heart J; 1988 Aug; 116(2 Pt 2):637-44. PubMed ID: 3293408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Arterial hypertension, left ventricular hypertrophy and arrhythmias].
    González Maqueda I
    Rev Esp Cardiol; 1991 Nov; 44(9):586-98. PubMed ID: 1723211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular mass and function before and after antihypertensive treatment.
    Lombardo M; Zaini G; Pastori F; Fusco M; Pacini S; Foppoli C
    J Hypertens; 1983 Oct; 1(3):215-9. PubMed ID: 6241622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium intake modulates left ventricular hypertrophy in essential hypertension.
    Schmieder RE; Messerli FH; Rüddel H; Garavaglia GG; Grube E; Nunez BD; Schulte W
    J Hypertens Suppl; 1988 Dec; 6(4):S148-50. PubMed ID: 2977158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of regression of left ventricular hypertrophy following sotalol therapy on diastolic function in hypertensive patients.
    Ibrahim MM; Zaghloul SS; Helmi SM
    J Hypertens Suppl; 1987 Dec; 5(5):S411-4. PubMed ID: 2965228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Malmqvist K; Ohman KP; Lind L; Nyström F; Kahan T
    J Cardiovasc Pharmacol; 2003 Dec; 42(6):719-26. PubMed ID: 14639093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy.
    Tubau JF; Szlachcic J; Braun S; Massie BM
    Hypertension; 1989 Jul; 14(1):1-8. PubMed ID: 2525526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; López B; Edner M; González A; Díez J; Malmqvist K
    J Hypertens; 2007 Sep; 25(9):1958-66. PubMed ID: 17762662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil.
    Angermann CE; Spes CH; Willems S; Dominiak P; Kemkes BM; Theisen K
    Circulation; 1991 Aug; 84(2):583-93. PubMed ID: 1830519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise systolic blood pressure: a powerful determinant of increased left ventricular mass in patients with hypertension.
    Ren JF; Hakki AH; Kotler MN; Iskandrian AS
    J Am Coll Cardiol; 1985 May; 5(5):1224-31. PubMed ID: 3157737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of beta 1-adrenoceptors in hypertensive cardiac hypertrophy.
    Lindpaintner K; Sen S
    J Hypertens; 1987 Dec; 5(6):663-9. PubMed ID: 2828468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
    Thürmann PA; Kenedi P; Schmidt A; Harder S; Rietbrock N
    Circulation; 1998 Nov; 98(19):2037-42. PubMed ID: 9808602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of captopril on the hypertrophied heart of essential hypertensive patients.
    Furuno Y; Nakashima Y; Fujita M; Sako R; Kuroiwa A
    J UOEH; 1990 Dec; 12(4):379-87. PubMed ID: 2149616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension.
    Pierdomenico SD; Bucci A; Manunta P; Rivera R; Ferrandi M; Hamlyn JM; Lapenna D; Cuccurullo F; Mezzetti A
    Am J Hypertens; 2001 Jan; 14(1):44-50. PubMed ID: 11206678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.